These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1389 related items for PubMed ID: 27476114

  • 1. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 30; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 3. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
    Li X, Zheng J, Chen L, Diao H, Liu Y.
    Mol Neurobiol; 2016 Jan 30; 53(1):577-583. PubMed ID: 25502291
    [Abstract] [Full Text] [Related]

  • 4. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
    Wei X, Chen D, Lv T, Li G, Qu S.
    Mol Neurobiol; 2016 Jan 30; 53(1):163-170. PubMed ID: 25416859
    [Abstract] [Full Text] [Related]

  • 5. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A, Izadpanahi M, Arab A, Zare-Mirzaei A, Minaeian S, Rostami A, Mohsenian A.
    Clin Neurol Neurosurg; 2020 Mar 30; 190():105652. PubMed ID: 31896490
    [Abstract] [Full Text] [Related]

  • 6. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
    Jin Z, Jin RH, Ma C, Li HS, Xu HY.
    J BUON; 2017 Mar 30; 22(2):474-480. PubMed ID: 28534372
    [Abstract] [Full Text] [Related]

  • 7. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y.
    Int J Clin Exp Pathol; 2015 Mar 30; 8(6):6576-88. PubMed ID: 26261539
    [Abstract] [Full Text] [Related]

  • 8. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.
    Int J Cancer; 2013 Jan 01; 132(1):116-27. PubMed ID: 22674182
    [Abstract] [Full Text] [Related]

  • 9. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y, Alivand M, Mollanoori H.
    Comput Biol Chem; 2021 Jun 01; 92():107458. PubMed ID: 33761401
    [Abstract] [Full Text] [Related]

  • 10. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J, Yang L, Wang X.
    Cancer Biomark; 2017 Dec 06; 20(4):521-526. PubMed ID: 28946553
    [Abstract] [Full Text] [Related]

  • 11. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H.
    Cancer Biomark; 2019 Dec 06; 24(1):43-49. PubMed ID: 30530966
    [Abstract] [Full Text] [Related]

  • 12. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X.
    Cell Oncol (Dordr); 2018 Feb 06; 41(1):25-33. PubMed ID: 29076027
    [Abstract] [Full Text] [Related]

  • 13. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017 Feb 06; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 14. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S, Xu Z, Zhang C, Yu R, Jiang J, Wang C, Qu C.
    Biomed Res Int; 2020 Feb 06; 2020():2102645. PubMed ID: 33083454
    [Abstract] [Full Text] [Related]

  • 15. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.
    Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
    Ohno M, Matsuzaki J, Kawauchi J, Aoki Y, Miura J, Takizawa S, Kato K, Sakamoto H, Matsushita Y, Takahashi M, Miyakita Y, Ichimura K, Narita Y, Ochiya T.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1916953. PubMed ID: 31808923
    [Abstract] [Full Text] [Related]

  • 17. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG, Emekdas G, Tezcan S, Ulger M, Serin MS, Sezgin O, Altintas E, Tiftik EN.
    Mol Biol Rep; 2014 Jul 02; 41(7):4513-9. PubMed ID: 24595450
    [Abstract] [Full Text] [Related]

  • 18. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A, Romeo SG, Cama A, La Torre D, Barresi V, Pezzino G, Tomasello C, Cardali S, Angileri FF, Polito F, Ferlazzo G, Di Giorgio R, Germanò A, Aguennouz M.
    Tumour Biol; 2016 Oct 02; 37(10):14035-14048. PubMed ID: 27495233
    [Abstract] [Full Text] [Related]

  • 19. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K.
    J Exp Clin Cancer Res; 2012 Nov 22; 31(1):97. PubMed ID: 23174013
    [Abstract] [Full Text] [Related]

  • 20. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
    Lucas Grzelczyk W, Szemraj J, Kwiatkowska S, Józefowicz-Korczyńska M.
    Diagn Pathol; 2019 May 28; 14(1):49. PubMed ID: 31138255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.